Noun
canagliflozin (uncountable)
(pharmacology) A drug C24H25FO5S·½H2O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet.
Canagliflozin Renal Outcomes Study Is Halted Early for Efficacy Hope that observed renoprotective effects of SGLT2 inhibitors will delay worsening of kidney disease in type 2 diabetes seems to be borne out, as the CREDENCE trial is stopped early. Source: Internet
Canagliflozin blocks the action of SGLT2. Source: Internet